Peripheral vascular disease will be addressed through peer discussion and resident/student education pertaining to common and uncommon general and vascular surgery patients. Special attention will be placed on identifying and treating common causes of morbidity and mortality associated with surgical patients. Despite advances in medicine morbidity and mortality rates remain a constant challenge for practicing surgeons. Knowledge of these issues is required to make improvements in our practice and to learn from our colleagues complications helps to improve our future competence and performance.
- Vascular surgeons
- Surgical residents
- Medical students
- Allied Health Professionals
At the conclusion of this activity, I will be able to:
- Decrease the rate of early thrombosis of fempop grafts.
- Better selection of patients who will benefit from endovascular treatment of femoral disease, and incorporation of new technology (drug elution and covered stents) as appropriate.
- Increase the rate of fistula creation and maturation.
All persons in control of content have NO relevant financial relationship to disclose with the exception of the following persons:
Name | Company | Role |
Allan Pasch, MD | BioConect Systems | Research |
Anthony Nelson, MD | Stealth Therapeutics | Speaking/teaching |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.